ISOP_Logo_Final
+1-908-253-3608
info@go-isop.org
Facebook
Twitter
LinkedIn
YouTube
  • About ISoP
    • Constitution and By-laws
    • Five-Year Strategic Plan
    • Leadership Team
    • Awards
    • ISoP Fellows
    • Member Spotlight
    • Logo Usage Policies
    • Communications Guidelines
    • Memorial Policy
    • discuss.go-isop.org
    • Photo Gallery (Flickr)
    • Contact Us
  • Events
    • ACoP
    • PAGE
    • WCoP
    • AAPS
    • ACCP
    • ASCPT
    • PAGANZ
    • PAGJA
    • Pharmacometrics Network Benelux
    • PKUK
    • RedIF
    • SUP
  • Membership
    • Member Profile
    • Join
    • Renew
    • Volunteer
  • Training Material
    • Tutorials
    • ISoP YouTube Channel
    • Shiny Server
    • Resources
  • SIGs
    • Clinical Pharmacometrics
    • Mathematical and Computational Sciences (MCS)
    • Quantitative Systems Pharmacology (QSP)
    • Statistics and Pharmacometrics (SxP)
  • Committees
    • Awards Committee
    • Communications Committee
    • Conference Committee
    • Diversity Equity & Inclusion (DE&I) Committee
    • Education Committee
    • Executive Committee
    • Finance Committee
    • Membership Committee
    • Nominations Committee
    • Scientific Partnership Committee
    • Standards & Best Practices Committee
    • Technology Committee
  • Trainee Community
  • Local Groups
    • Midwest
    • New England
    • NJ/PA/NY
  • Official Journals
    • Recent Publications
    • Newsletters
  • Career Center

Five-Year Strategic Plan

Home Five-Year Strategic Plan

Five-Year Vision

By 2023, the International Society of Pharmacometrics (ISoP) will be the premier organization advancing the discipline of pharmacometrics throughout the world.  ISoP will actively champion the expanding role of pharmacometrics in protecting and improving human health, by:

  • Broadening ISoP’s outreach to become a truly international society, increasing membership by 50%, and sponsoring pharmacometrics meetings worldwide.
  • Increasing the awareness of key decision-makers, such as regulators, clinicians, payers (anyone setting pricing or reimbursement policies), patient advocates, and industry leadership, to the impact of pharmacometrics on drug discovery, development, and clinical practice.
  • Strengthening core pharmacometric capabilities through research support and educational initiatives, while increasing the exposure of society members to new areas, such as health economics and machine learning.
  • Improving development of and access to educational resources, pharmacometrics tools, and open-science resources for society members at every stage of their career.

Core Activity Areas

We have identified the following six areas for our core activity under the Five-Year Strategic Plan. Working groups will be established to plan and implement each of these. 

  • Scientific Expertise and Innovation
  • Influence
  • Education
  • Tools and Resources
  • Internationalization
  • Organizational Effectiveness
ISoP Five-Year Strategy Synopsis (May 2019)Download

     

What’s New

  • Introducing ISoP President-Elect: Vijay Ivaturi, Ph.D. November 30, 2022
  • Meet ISoP Member Dr. Stephen Greene July 5, 2022
  • ACoP13 Registration is Open! June 6, 2022

ISoP Membership

  • Join Now
  • Benefits
Copyright 2021 by ISoP
Privacy Statement

International Society of Pharmacometrics
1200 Rt 22E Suite 2000
Bridgewater, NJ 08807
United States

+1-908-253-3608
info@go-isop.org
@ISoP1